Finance

Lists
Q3 2026 earnings • released • EPS beat +11.13%
See results
PRAX:NASDAQ
Praxis Precision Medicines Inc
$332.97
+19.94%
(+55.35) 1D
$332.00
-0.29% (-0.97)
After hours
Closed: Nov 9, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRAX...
Open
$285.00
High
$335.18
Low
$279.14
Mkt. cap
9.30B
Avg. vol.
481.37K
Volume
1.12M
52-wk high
$392.70
52-wk low
$160.11
EPS
-$12.93
Beta
2.85
Shares outstanding
27.92M
No. of employees
168
Open
$285.00
High
$335.18
Low
$279.14
Mkt. cap
9.30B
Avg. vol.
481.37K
Volume
1.12M
52-wk high
$392.70
52-wk low
$160.11
EPS
-$12.93
Beta
2.85
Shares outstanding
27.92M
No. of employees
168
News stories
From web sources and news partners
About Praxis Precision Medicines Inc
CEO-
Employees168
Founded2015
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitepraxismedicines.com
Analyst ratings
Based on 11 analysts giving stock ratings to PRAX in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PRAX in the last 3 months.
Highest
Current $332.97
$1,201.00 (+260.69%)
Average
$752.82 (+126.09%)
Lowest
$362.00 (+8.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$1,200.00
+260.4%
11/09/2026
Kambiz Yazdi
BTIG
Buy
Maintained
$826.00
+148.1%
11/02/2026
Benjamin Burnett
Wells Fargo
Hold
Maintained
$362.00
+8.7%
10/16/2026
Tessa Romero
J.P. Morgan
Buy
Initiated
$700.00
+110.2%
10/15/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
$1,201.00
+260.7%
10/15/2026
Joon Lee
UBS
Buy
Initiated
$706.00
+112%
10/15/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$534.00
+60.4%
10/01/2026
Ami Fadia
Needham
Buy
Reiterated
$582.00
+74.8%
09/24/2026
Kevin Strang
Goldman Sachs
Buy
Reiterated
$575.00
+72.7%
08/21/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$650.00
+95.2%
08/17/2026
Tiago Fauth
Raymond James
Buy
Maintained
$945.00
+183.8%
08/17/2026
Danielle Brill
Truist Financial
Buy
Maintained
$616.00
+85%
08/07/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$800.00
+140.3%
08/06/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
$514.00
+54.4%
08/07/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
$462.00
+38.8%
08/06/2026
Ritu Baral
TD Cowen
Buy
Maintained
$510.00
+53.2%
08/06/2026
Francois Brisebois
LifeSci Capital
Buy
Reiterated
$754.00
+126.4%
08/08/2026
Andrew Tsai
Jefferies
Buy
Maintained
$550.00
+65.2%
06/30/2026
Laura Chico
Wedbush
Sell
Maintained
$162.00
-51.3%
06/02/2026
David Hoang
Deutsche Bank
Buy
Maintained
$374.00
+12.3%
06/02/2026
Unknown Analyst
Raymond James
Buy
Initiated
$815.00
+144.8%
04/08/2026
Rudy Li
Wolfe Research
Buy
Maintained
$500.00
+50.2%
04/06/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
-$3.23 / -$3.63
+11.13%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
65.80M
77.51M
77.99M
69.42M
Cost of revenue
65.80M
77.51M
77.99M
69.42M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.56M
19.54M
27.87M
27.49M
Operating expense
12.56M
19.54M
27.87M
27.49M
Total operating expenses
78.36M
97.04M
105.86M
96.90M
Operating income
-78.36M
-97.04M
-105.86M
-96.90M
Other non operating income
-
-
-
-
EBT including unusual items
-73.93M
-88.91M
-92.56M
-83.72M
EBT excluding unusual items
-73.93M
-92.50M
-93.22M
-83.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-73.93M
-88.91M
-92.56M
-83.72M
Net profit margin
-
-
-
-
Earnings per share
-3.36
-3.50
-3.20
-2.87
Interest and investment income
4.42M
4.54M
12.64M
13.18M
Interest expense
-
-
-
-
Net interest expenses
4.42M
4.54M
12.64M
13.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
-78.34M
-97.02M
-105.82M
-96.87M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps